Zhang, C., Zhu, X., Li, L., Ma, T., Shi, M., Yang, Y., & Fan, Q. (2019). A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation. Diabetes Metab Syndr Obes.
Citação norma ChicagoZhang, CongXiao, XinWang Zhu, LuLu Li, TianKui Ma, Mai Shi, Ying Yang, and QiuLing Fan. "A Small Molecule Inhibitor MCC950 Ameliorates Kidney Injury in Diabetic Nephropathy By Inhibiting NLRP3 Inflammasome Activation." Diabetes Metab Syndr Obes 2019.
MLA CitationZhang, CongXiao, et al. "A Small Molecule Inhibitor MCC950 Ameliorates Kidney Injury in Diabetic Nephropathy By Inhibiting NLRP3 Inflammasome Activation." Diabetes Metab Syndr Obes 2019.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.